GUILLERMO GARCIA-MANERO to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
0.278
-
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase?III?Trial. Clin Lymphoma Myeloma Leuk. 2019 04; 19(4):213-219.e4.
Score: 0.116
-
A pilot pharmacokinetic study of oral azacitidine. Leukemia. 2008 Sep; 22(9):1680-4.
Score: 0.056
-
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 2008 Feb 01; 111(3):1060-6.
Score: 0.054
-
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome. Blood. 2007 Oct 01; 110(7):2302-8.
Score: 0.052